Advertisement

Schwangerenvorsorge

  • Wolfgang HeylEmail author
  • Jürgen Wacker
Chapter
  • 25 Downloads

Zusammenfassung

Gesunde Frauen, befragt nach ihren Erwartungen an ihre Schwangerschaft und Geburt antworteten: „Aufrechterhaltung der körperlichen und soziokulturellen Normalität, eine unauffällig verlaufende, gesunde Schwangerschaft, ein problemloser Übergang in effektive Geburtswehen und Geburt sowie eine positive Mutterschaft.“ Unbestritten ist, dass eine Schwangerenvorsorge im Vergleich zu keiner Vorsorge Leben retten kann. In Deutschland ist die Schwangerenvorsorge gesetzlich durch die sogenannten „Mutterschafts-Richtlinien“ des Gemeinsamen Bundesausschusses (G-BA) geregelt. Dabei ist „... das vorrangige Ziel der ärztlichen Schwangerenvorsorge ... die frühzeitige Erkennung von Risikoschwangerschaften und Risikogeburten.“ Besondere Erwähnung findet neben der Vermeidung unnötiger Kosten auch die Forderung, dass nur Maßnahmen angewendet werden sollen, deren diagnostischer und vorbeugender Wert ausreichend gesichert ist. Aber gerade unter diesen gibt es auch Maßnahmen, die nicht ausreichend untersucht oder gar evidenzbasiert sind. Das vorliegende Kapitel will etablierte Vorsorgeuntersuchungen unter dem Gesichtspunkt der Aktualität und der Evidenz kritisch beleuchten.

Literatur

  1. Abbassi-Ghanavati M, Greer LG, Cunningham FG (2009) Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 114:1326–1331CrossRefPubMedPubMedCentralGoogle Scholar
  2. ACOG Committee Opinion No 381 (2007) Subclinical hypothyroidism in pregnancy. Obstet Gynecol 110:959Google Scholar
  3. Agathokleous M, Chaveeva P, Poon LCY, Kosinkski P, Nicolaides K (2013) Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynacol 41:247–261CrossRefGoogle Scholar
  4. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH (2008) Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32:732–739CrossRefPubMedPubMedCentralGoogle Scholar
  5. Akolekar R, de Cruz J, Foidart JM, Munaut C, Nicolaides KH (2010) Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia. Prenat Diagn 30:191–197CrossRefPubMedPubMedCentralGoogle Scholar
  6. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH (2011) Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 31:66–74CrossRefPubMedPubMedCentralGoogle Scholar
  7. Alexander EK et al (2017) Guidelines of the American thyroid association of the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27:315CrossRefPubMedPubMedCentralGoogle Scholar
  8. Alvarez JR, Fechner AJ, Williams SF et al (2010) Asymptomatic bacteriuria in pregestational diabetic pregnancies and the role of group B streptococcus. Am J Perinatol 27:231CrossRefPubMedPubMedCentralGoogle Scholar
  9. AWMF Leitlinie Register Nr.: 015/036 (2013a) Anwendung des CTG währrend Schwangerschaft und GeburtGoogle Scholar
  10. AWMF Leitlinie Register Nr.: 015-018 (2013b) Diagnostik und Therapie hypertensiver SchwangerschaftserkrankungenGoogle Scholar
  11. AWMF Leitlinie Register Nr.: 057-008 (2018) Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und NachsorgeGoogle Scholar
  12. Bramham K et al (2014) Chronic hypertension and pregnancy outcomes: a systematic review. BMJ 348:g2301.  https://doi.org/10.1136/bmj.g2301CrossRefPubMedPubMedCentralGoogle Scholar
  13. Breese P, Burman W, Shlay J, Guinn D (2004) The effectiveness of a verbal opt out system for human immunodeficiency virus screening during pregnancy. Obstet Gynecl 104:134CrossRefGoogle Scholar
  14. Bricker I, Neilson JP (2000) Routine ultrasound in late pregnancy (after 24 weeks of gestation). Cochrane Database Syst Rev 2:CD001451Google Scholar
  15. Buekens P, Alexander S, Boutsen M, Blondel B, Kaminski M, Reid M (1994) Randomised controlled trial of routine cervical examinations in pregnancy. European community collaborative study group on prenatal screening. Lancet 344(8926):841–844CrossRefGoogle Scholar
  16. Buzyan LO (2015) Mild anemia as a protective factor against pregnancy loss. Int J Risk Saf Med 27(Suppl. 1):S7–S8CrossRefGoogle Scholar
  17. Clausen FB, Steffensen R, Christiansen M et al (2014) Routine noninvasive prenatal screening for fetal RHD in plasma of RHD-negative pregnant women – 2 years screening experience for Denmark. Prenat Diagn 34:1000–1005CrossRefGoogle Scholar
  18. Clearly-Goldman J et al (2005) Impact of maternal age on obstetric outcome. Obstet Gynacol 105:983–990CrossRefGoogle Scholar
  19. Clearly-Goldman J et al (2008) Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 112:85–92CrossRefGoogle Scholar
  20. Cluver C, Novikova N, Eriksson DOA, Bengtsson K, Lingman GK (2017) Intervention for treating chlamydia trachomatosis infection in pregnancy Cochrane Database Syst Rev 9:CD010485Google Scholar
  21. Cnattingius S et al (2013) Maternal obesity an risk of preterm delivery. JAMA 209:2362–2370CrossRefGoogle Scholar
  22. Cnossens JS et al (2008) Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ 336:1117CrossRefGoogle Scholar
  23. Connor EM, Sperling RS, Gelber R et al (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group. N Engl J Med 331:1173–1180CrossRefPubMedPubMedCentralGoogle Scholar
  24. Crowley P (2000) Interventions for preventing or improving the outcome of delivery at or beyond term. Cochrane Database Syst Rev 2:CD000170Google Scholar
  25. Czeizel AE, Dudas I (1992) Prevention of the first occurence of neural-tube defects by periconceptional vitamine supplementation. N Engl J Med 327:1832–1835CrossRefPubMedPubMedCentralGoogle Scholar
  26. Dawes MG, Grudzinskas JG (1991) Repeated measurement of maternal weight during pregnancy. Is this a useful practice? Br J Obstet Gynaecol 98(2):189–194CrossRefPubMedPubMedCentralGoogle Scholar
  27. Deutsche Gesellschaft für Ernährung (DGE) (2017) Referenzwerte für die Nährstoffzufuhr. BonnGoogle Scholar
  28. Die Drogenbeauftrage der Bundesregierung Bundesministerium für Gesundheit. Hrsg: Drogen und Suchtbericht Juni 2016Google Scholar
  29. Downe S et al (2016) What matters to women: a systematic scoping review to identify the processes and outcomes of antenatal care provision that are important to healthy pregnant women. BJOG 123:529CrossRefPubMedPubMedCentralGoogle Scholar
  30. Dowswell T et al (2015) Alternative versus standard packages of antenatal care for low-risk pregnancy. Cochrane Database Syst Rev 2015, Issue 7Google Scholar
  31. FAO/WHO/UNU Expert Consultation (2005) Food Nutr Bull 26:166CrossRefGoogle Scholar
  32. Flak AL, Su S, Bertrand J et al (2014) The association of mild, moderate and high alcohol exposure and child neuropsychological outcome: a meta-analysis. Alcohol Clin Exp Res 38:214–226CrossRefPubMedPubMedCentralGoogle Scholar
  33. Gardosi J et al (1999) Controlled trial of fundal height measurement plotted on customised antenatal growth charts. BJOG 106:309CrossRefGoogle Scholar
  34. Gemeinsamer Bundesausschuss (G-BA) (2016) Richtlinien über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung („Mutterschafts-Richtlinien“) zuletzt geändert am 21. April 2016, veröffentlich im Bundesanzeiger AT 19.07.2016 B5, in Kraft getreten am 20. Juli 2016Google Scholar
  35. Goh BT, van Voorst Vader PC (2001) European guideline for the management of syphilis. Int J STD AIDS 12(Suppl 3): 14–26Google Scholar
  36. Golan A, Wexler S, Amit A et al (1989) Asymptomatic bacteriuria in normal and high-risk pregnancy. Eur J Obstet Gynecol Reprod Biol 33:101CrossRefGoogle Scholar
  37. Granfors M et al (2014) Targeted thyroid testing during pregnancy in clinical practice. Obstet Gynecol 124:10–15CrossRefGoogle Scholar
  38. Grivel RM, Alfirevic Z, Gyte GM, Devane D (2010) Antenatal cardiotocography for foetal assessment. Cochrane Database Syst Rev 1:CD007863Google Scholar
  39. Hawkes SJ, Gomez GB, Broutet N (2013) Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis. PLoS ONE 8:e56713.  https://doi.org/10.1371/journal.pone.0056713CrossRefPubMedPubMedCentralGoogle Scholar
  40. Heilmann L et al (1993) Das Hämoglobin – ein geburtshilflicher Risikofaktor? Geburtsh Frauenheilk 53:235–239CrossRefGoogle Scholar
  41. Henderson JT et al (2017) Preeclampsia screening – evidence report and systematic review for the US preventive service task force. JAMA 317:1668–1683CrossRefPubMedPubMedCentralGoogle Scholar
  42. Higgins JR, De Swiet M (2001) Blood-pressure managment and classification. Lancet 357:1326–1341CrossRefGoogle Scholar
  43. Ingraham NR (1950) The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol Suppl 31:60–87Google Scholar
  44. Kainer F (2007) Ärztliche Betreuung in der Schwangerschaft. In: Kiechle M (Hrsg) Gynäkologie und Geburtshilfe. Urban & Fischer, MünchenGoogle Scholar
  45. Kaunitz AM, Spence C, Danielson TS et al. (1984) Perinatal and maternal mortality in a religious group avoiding obstetric care. AJOG 150:826CrossRefGoogle Scholar
  46. Keegan MB, Diedrich JT, Peipert JF (2014) Chlamydia trachomatis infection: screening and management. J Clin Outcomes Manag 21:30–38PubMedPubMedCentralGoogle Scholar
  47. Kesmodel US, Bertrand J, Stovring H et al (2012) The effect of different alcohol drinking patterns in early to mid pregnancy on the childs’s intelligence, attention and executive function. BJOG 119:1180–1190CrossRefPubMedPubMedCentralGoogle Scholar
  48. Khalil A et al (2013) Maternal age and adverse pragnancy outcom: a cohort study. Ultrasound Obstet Gynecol 42:634–643CrossRefPubMedPubMedCentralGoogle Scholar
  49. Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos RJ, Pulkkinen A et al (1991) Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 35:41–46CrossRefGoogle Scholar
  50. Koletzko B, Pietrzik K (2004) Gesundheitliche Bedeutung der Folsäurezufuhr. Dtsch Ärztebl 101:A-1670/B-1388/C-1338Google Scholar
  51. Koletzko B, Schiess S, Brands B et al (2010) Infant feeding practice and later obesity risk. Indications for early metabolic programming. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53:666–673CrossRefGoogle Scholar
  52. Koletzko B, Cremer M, Flothkötter M et al (2018) Ernährung und Lebensstil vor und während der Schwangerschaft – Handlungsempfehlungen des bundesweiten Netzwerkes Gesund ins Leben. Geburtshilfe & Frauenheilkunde, GebFra ScienceGoogle Scholar
  53. Kuc S et al (2013) Maternal characteristics. Mean arterial pressure and serum markers in early prediction of preeclamsia, PLOS.  https://doi.org/10.1371/journal.pone.0063546CrossRefGoogle Scholar
  54. Lao TT et al (2006) Maternal age and prevalence of gestational diabetes mellitus. Diab Care 29:948–949CrossRefGoogle Scholar
  55. Lee V, Tobin JM, Foley E (2006) Relationship of cervical ectopy to chlamydia infection in young women. J Fam Plann Reprod Health Care 32:104–106CrossRefGoogle Scholar
  56. Levran D, Shoham Z, Geranek M, Greenwald M, Mashiach S (1988) The value of amnioscopy in surveillance of postdate pregnancy. Aust N Z J Obstet Gynaecol 28:271–274CrossRefGoogle Scholar
  57. Lindheimer MD, Kanter D (2010) Interpreting abnormal proteinuria in pregnancy. Obstet Gynecol 115(2):365–375CrossRefPubMedPubMedCentralGoogle Scholar
  58. Luke B, Brown MB (2007) Elevated risks of pregnancy complications and adverse outcomes with increasing maternal age. Hum Reproduction 22:1264–1272CrossRefGoogle Scholar
  59. Moller AB et al (2017) Early antenatel care visit: a systematic analysis of regional and global levels and trends of coverage from 1990 to 2013. Lancet Glob Health 5:e977CrossRefPubMedPubMedCentralGoogle Scholar
  60. NICE Clinical Guidelines No.62. National collaborating centre for women’s and children’s health – commissioned by the National Institute for Health and Clinical Excellence; Royal College of Obstetricians and Gynaecologists. Routine care for the healthy pregnant woman (2008)Google Scholar
  61. Nicolle LE, Bradley S, Colgan R et al (2005) Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40:643CrossRefPubMedPubMedCentralGoogle Scholar
  62. Ochsenbein-Kölble N, Roos M, Gasser T, Zimmermann R (2007) Cross-sectional study of weight gain and increase in BMI throughout pregnancy. Eur J Obstet Gynaecol Reprod Biol 130:180–186CrossRefGoogle Scholar
  63. Oken E (2015) Routine weighing of women in pregnancy is of limited value and should be abandonned – Against. BJOG 122:1101CrossRefPubMedPubMedCentralGoogle Scholar
  64. Ong JJ, Chen M, Hocking J et al (2015) Chlamydia screening für pregnant women aged 16–25 years attending an antenatal service: a cost-effectiveness study. BJOG 123:1194–1202CrossRefPubMedPubMedCentralGoogle Scholar
  65. Owusu-Edusei K, Chesson HW, Leichliter JS et al (2013) The association between racial disparity in income and reported sexually transmitted infections. Am J Public Health 103:910–916CrossRefPubMedPubMedCentralGoogle Scholar
  66. Patterson F, Andriole VT (1997) Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am 11:593CrossRefGoogle Scholar
  67. Pattison N, McCowan L (2010) Cardiotocography for antepartum fetal assessment. Cochrane Database Syst Rev 2:CD 001066Google Scholar
  68. Pschyrembel W (1973) Praktische Geburthilfe, 14. Aufl. De Gruyter, BerlinGoogle Scholar
  69. Rahman MM, Abe SK, Rahman MS et al (2016) Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr 103:495–504CrossRefGoogle Scholar
  70. Rasmussen KM, Abrams B, Bodnar LM et al (2010) Recommendations for weight gain during pregnancy in the context oft he obesity epidemic. Obstetrics Gynecology 116:1191–1195CrossRefGoogle Scholar
  71. Robert-Koch-Institut (2016) Syphilis in Deutschland im Jahr 2015: Weiterer verstärkter Anstieg von Syphilis-Infektionen bei Männern, die Sex mit Männern haben. Epid Bull 50/2016  https://doi.org/10.17886/epibull-2016-bull 50/2016
  72. Robert-Koch-Institut (2017) Schätzung der HIV-Neuinfektionen und der Gesamtzahl der Menschen mit HIV-Infektion in Deutschland Epid Bull 47/2017Google Scholar
  73. Rongkavilit C, Asmar BI (2011) Advances in prevention of mother-to-child HIV transmission: the international perspectives. Indian J Pedietr 78:194–204Google Scholar
  74. Ros HS, Cnattingius S, Lipworth L (1998) Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 147:1062CrossRefGoogle Scholar
  75. Schild RL (2016) Schwangerschaftsvorsorge. In: Schneider H, Husslein P, Scheider KTM (Hrsg) Die Geburtshilfe. Springer, Berlin, S 191–202CrossRefGoogle Scholar
  76. Schild RL, Wacker J (2013) Schwangerenvorsorge. In: Wacker J et al (Hrsg) Therapiehandbuch Gynäkologie und Geburtshilfe. Springer, Berlin, S 31–42CrossRefGoogle Scholar
  77. Schnarr J, Smaill F (2008) Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest 38(Suppl 2):50CrossRefGoogle Scholar
  78. Sibai BM, Lindheimer M, Hauth J et al (1998) Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National institute of child health and human development network of maternal-fetal medicine units. N Engl J Med 339:667CrossRefGoogle Scholar
  79. Siemer J, Schild RL, Hoopmann M (2013) Neurungen im Mutterpass und pränatalen Ultraschall. Geburtsh Frauenheilkd 73:R49–R62CrossRefGoogle Scholar
  80. Smaill FM, Vazquez JC (2015) Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev:CD000490Google Scholar
  81. Sobel JD, Kaye D (2010) Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R (Hrsg) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 7, vol 1. Elsevier, Philadelphia, S 957CrossRefGoogle Scholar
  82. SOGC (2007) Clinical practice guideline fetal health surveillance: antepartum and intrapartum consensus guideline no. 197Google Scholar
  83. Soothill PW, Finning K, Latham T et al (2014) Use off cffDNA to avoid administration of anti-D to pregnant women when the fetus is RHD-negative. BJOG 122:1682–1686CrossRefPubMedPubMedCentralGoogle Scholar
  84. Spencer L, Bubner T, Bain E, Middleton P (2015) Screenin and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health. Cochrane Database Syst Rev 9:CD011263.  https://doi.org/10.1002/14651858.cd011263.pub2CrossRefGoogle Scholar
  85. Ständige Impfkommission (STIKO) am Robert Koch – Institut (2010) Änderung der Empfehlung zur Impfung gegen Influenza. Epidemiologisches Bull 31:299–309Google Scholar
  86. Steer PJ (2015) Routine weighing of women in pregnancy is of limited value and should be abandonned – For. BJOG 122:1101CrossRefPubMedPubMedCentralGoogle Scholar
  87. Stubert J, Reister F, Hartmann S, Janni W (2018) Dtsch Ärztebl 115:276–283Google Scholar
  88. Stück B, Parasher KS, Bartsch M (2001) Generelles Hepatitis-B-Screening. Dtsch Ärztebl 98:A329–A331Google Scholar
  89. Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM (2013) The definition of severe and early- onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens 3:44–47CrossRefPubMedPubMedCentralGoogle Scholar
  90. Villar J, Carroli G, Khan-Neelofur D, Piaggio G, Gulmezoglu M (2001) Patterns of routine antenatal care for low-risk pregnancy. Cochrane Database Syst Rev 4:CD000934Google Scholar
  91. Voigt M (2005) Häufigkeitsverteilung der Schwangerschaftsrisiken. In: Rath W, Friese K (Hrsg) Erkrankungen in der Schwangerschaft. Georg Thieme, Stuttgart 2–4Google Scholar
  92. Vural T, Toz E, Ozcan A et al (2016) Can anemia predict perinatal outcomes in different stages of pregnancy? Pak J Med 32:1354–1359Google Scholar
  93. Wacker J: Eine Last fürs Leben Interview; BNN 26.03.2019Google Scholar
  94. Walker GJ (2001) Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev 3:CD 001143Google Scholar
  95. Wallwiener D (2016) 237. Stellungnahme der DGGG zu dem Thema „Nichtinvasive Bestimmung des fetalen Rhesusfaktors zur Vermeidung einer mütterlichen Rhesus-Sensibilisierung im Rahmen der Vorsorgeuntersuchung gemäß Mutterschafts-Richtlinien (Mu-RL)“ https://www.dggg.de/fileadmin/documents/stellungnahmen/aktuell/2016/237_Rh-Sensibilisierung_im_Rahmen_der_Vorsorge_gemaess_Mu-RiLi.pdf
  96. Walmsley S (2003) Opt in or opt out: what is oprimal for prenatal screening for HIV infectuion? CMAJ 168:707PubMedPubMedCentralGoogle Scholar
  97. Weichert A, Henrich W (2016) Von der Geburtshilfe zur Geburtsmedizin Gynäkologe 49:499–505Google Scholar
  98. Westergaard HB, Langhoff-Roos J, Lingman G, Marsal K, Kreiner S (2001) A critical appraisal in high-risk pregnancies: use of meta-analysis in evidence-based obstetrics. Ultrasound Obstet Gynecol 17:466–476CrossRefPubMedPubMedCentralGoogle Scholar
  99. WHO (2017) Urinary iodine concentrations for determing iodine status in populations. Online: http://app.who.int/irisbitstream/10665
  100. Wong VC, Ip HM, Reesink HW et al (1984) Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administartion of hepatitis-B vaccine and hepatitis-B immunglobulin. Double-blind randomised placebo-controlled study. Lancet 1(8383):921–926PubMedPubMedCentralGoogle Scholar
  101. Workowski KA, Bolan GA (2015) Center for disease control and prevention sexually transmitted disease treatment guidelines. MMWR Recomm Rep 61:1Google Scholar
  102. World Health Organization (2014) Investment case for eliminating mother-to-child transmission of syphilis. http://www.who.int/reproductivehealth/publications
  103. Yim CH (2016) Update on the management of thyroid disease during pregnancy. Endocrinol Metab 31:386–391CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.Klinik für Frauenheilkunde und GeburtshilfeKlinikum LudwigsburgLudwigsburgDeutschland
  2. 2.Fürst-Stirum-Klinik Bruchsal FrauenklinikBruchsalDeutschland

Personalised recommendations